|
Federal
Register Notices > Notices
of Registration - 2004 > Sigma
Aldrich Research Biochemicals, Inc
FR Doc 04-5771
[Federal Register: March 15, 2004 (Volume 69, Number 50)]
[Notices]
[Page 12181-12182]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15mr04-114]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice
of Registration
By Notice dated November 14, 2003, and published
in the Federal Register on December 2, 2003, (68 FR 67479), Sigma
Aldrich Research Biochemicals, Inc., 1-3 Strathmore Road, Natick,
Massachusetts 01760, made application by renewal to the Drug Enforcement
Administration for registration as a bulk manufacturer of the basic
classes of controlled substances listed below:
| Drug |
Schedule |
| Cathinone (1235) |
I |
| Methcathinone (1237) |
I |
| Aminorex (1585) |
I |
| Alpha-ethyltryptamine (7249) |
I |
| Lysergic acid diethylamide
(7315) |
I |
| Tetrahydrocannabinols (7370) |
I |
| 4-Bromo-2,5-dimethoxy-amphetamine
7391 |
I |
| 4-Bromo-2,5-dimethoxyphenethylamine
(7392) |
I |
| 2,5-Dimethoxyamphetamine (7396) |
I |
| 3,4-Methylenedioxyamphetamine
(7400) |
I |
| N-Hydroxy-3,4-methylenedioxyamphetamine
(7402) |
I |
| 3,4-Methylenedioxy-N-ethylamphetamine
(7404) |
I |
| 3,4-Methylenedioxymethamphetamine
(MDMA) (7405) |
I |
| 1-[1-(2-thienyl)cyclohexyl]piperidine
(TCP) (7470) |
I |
| Heroin (9200) |
I |
| Normorphine (9313) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| 1-Phenylcyclohexylamine (7460) |
II |
| Phencyclidine (7471) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Diprenorphine (9058) |
II |
| Ecogonine (9180) |
II |
| Levomethorphan (9210) |
II |
| Levorphanol (9220) |
II |
| Meperidine (9230) |
II |
| Metazocine (9240) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Levo-alphacetylmethadol (9648) |
II |
| Carfentanil (9743) |
II |
| Fentanyl (9801) |
II |
The firm plans to manufacture the listed
controlled substances for laboratory reference standards and
neurochemicals.
No comments or objections have been received. DEA
has considered the factors in Title
21, United States Code, Section 823(a) and determined that the
registration of Sigma Aldrich Research Biochemicals, Inc. to manufacture
the listed controlled substances is consistent with the public interest
at this time. DEA has investigated Sigma Aldrich Research Biochemicals,
Inc. to ensure that the company's registration is consistent with the
public interest. This investigation has included inspection and testing
of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C. 823
and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office
of Diversion Control, hereby orders that the application submitted by
the above firm for registration as a bulk manufacturer of the basic
classes of controlled substances listed is granted.
Dated: March 5, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 04-5771 Filed 3-12-04; 8:45 am]
BILLING CODE 4410-09-M
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
Back to
Top
Registration
Support
Toll Free Number: 1-800-882-9539
ARCOS
| Career Opportunities | Chemical Program |
Controlled
Substance Schedules | Drugs and
Chemicals of Concern
Electronic Commerce Initiatives | | Federal Register
Notices | Import Export | Links
| Meetings
and Events | NFLIS
Offices &
Directories | On-Line Forms & Applications |
Program
Description | Publications
|
Questions & Answers | Quotas
Reports Required by 21 CFR | Title 21 Regulations & Codified
CSA
Contact Us | Home
| Hot
Items | Site Map | Search | What's New
|
